Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
The Vanguard Group reported a 5.13% stake in Monte Rosa Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Jan 30, 2025
The Vanguard Group reported a 5.13% stake in Monte Rosa Therapeutics, Inc., 3,156,354 shares, as a passive investor on Dec 31, 2024. Filed Jan 30, 2025 (Schedule 13G).
- Stake
- 5.13%
- Shares
- 3,156,354
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.13% | 3,156,354 |
Source
Related
- Monte Rosa Therapeutics, Inc.
- The Vanguard Group
- Monte Rosa Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Oct 31, 2025
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026